Value8 N.V. has successfully grown its investment portfolio and equity in the first half of 2025, driven by strategic acquisitions and continued focus on high-potential sectors.
Information on the Target
Value8 N.V., an investment firm, has experienced substantial growth in the first half of 2025. The company’s investment portfolio expanded from €110.0 million at the end of 2024 to €117.2 million by June 30, 2025. In this timeframe, Value8's equity rose by 5.7%, increasing from €103.0 million to €108.9 million. This positive trajectory reflects a 5.9% increase in the net asset value (NAV) per share, now standing at €10.24 after accounting for a €0.20 dividend.
In terms of revenue, Value8 reported income of €8.88 million during the first half of 2025. Although this figure shows a slight decline from the previous year's high of €9.99 million, the firm's overall financial health remains robust. Dividend income was recorded at €1.8 million, down from €3.0 million in the prior year. Additionally, the gains from publicly traded investments amounted to €6.18 million, slightly less than the €6.45 million recorded in the first half of 2024.
Access Full Deal Insights
You’re viewing a public preview of this deal. To unlock full access to ca. 50,000 other deals in our database and join ca. 400 M&A professionals who are using it daily, sign up for Dealert.
Industry Overview in The Target’s Country
In the Netherlands, the investment landscape is characterized by a diverse range of industries with increasing opportunities for growth. The Dutch economy has shown resilience and adaptability, making it an attracti
Similar Deals
Oranjewoud Participaties → Ynte Kuindersma Verzekeringen
Ardonagh Group → Private Insurance Nederland
You Sure → Maesstad and Maeshave Assuradeuren
Brookfield Asset Management → Oaktree Capital
2026
Value8 N.V.
invested in
Naviva Kraamzorg
in 2025
in a Other Private Equity deal
Disclosed details
Revenue: $9M
Net Income: $6M